These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 24642581

  • 21. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study.
    Bernstein CN, Nabalamba A.
    Am J Gastroenterol; 2006 Jan; 101(1):110-8. PubMed ID: 16405542
    [Abstract] [Full Text] [Related]

  • 22. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 23. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
    Zissimopoulos A, Vradelis S, Konialis M, Chadolias D, Bampali A, Constantinidis T, Efremidou E, Kouklakis G.
    Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
    [Abstract] [Full Text] [Related]

  • 24. Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis.
    Feagan BG, Sandborn WJ, Lazar A, Thakkar RB, Huang B, Reilly N, Chen N, Yang M, Skup M, Mulani P, Chao J.
    Gastroenterology; 2014 Jan; 146(1):110-118.e3. PubMed ID: 24067881
    [Abstract] [Full Text] [Related]

  • 25. Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases.
    Newby EA, Croft NM, Green M, Hassan K, Heuschkel RB, Jenkins H, Casson DH.
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):539-45. PubMed ID: 18493209
    [Abstract] [Full Text] [Related]

  • 26. Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.
    Iborra M, Beltrán B, Maroto N, Navarro-Cortés P, Boscá-Watts M, Ferrer-Bradley I, García-Morales N, Sáez-González E, Hinojosa J, Mínguez M, Nos P.
    Gastroenterol Hepatol; 2018 Nov; 41(9):535-543. PubMed ID: 30031573
    [Abstract] [Full Text] [Related]

  • 27. Presenting features and disease course of pediatric ulcerative colitis.
    Aloi M, D'Arcangelo G, Pofi F, Vassallo F, Rizzo V, Nuti F, Di Nardo G, Pierdomenico M, Viola F, Cucchiara S.
    J Crohns Colitis; 2013 Dec; 7(11):e509-15. PubMed ID: 23583691
    [Abstract] [Full Text] [Related]

  • 28. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T, Simonsen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M.
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Alexakis C, Saxena S, Chhaya V, Cecil E, Curcin V, Pollok R.
    Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N, Vatn MH, Moum B, Ibsen Study Group.
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [Abstract] [Full Text] [Related]

  • 33. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J, Vila V, Varea V.
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [Abstract] [Full Text] [Related]

  • 34. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 35. Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease.
    Larsen MD, Qvist N, Nielsen J, Kjeldsen J, Nielsen RG, Nørgård BM.
    J Crohns Colitis; 2016 Jun; 10(6):650-6. PubMed ID: 26802081
    [Abstract] [Full Text] [Related]

  • 36. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada.
    Moore SE, McGrail KM, Peterson S, Raval MJ, Karimuddin AA, Phang PT, Bressler B, Brown CJ.
    Dis Colon Rectum; 2014 Jan; 57(1):83-90. PubMed ID: 24316950
    [Abstract] [Full Text] [Related]

  • 37. Resource utilization before and during infliximab therapy in patients with inflammatory bowel disease.
    Waters HC, Vanderpoel JE, Nejadnik B, McKenzie RS, Lunacsek OE, Lennert BJ, Goff J, Augustyn DH.
    J Med Econ; 2012 Jan; 15(1):45-52. PubMed ID: 22023068
    [Abstract] [Full Text] [Related]

  • 38. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database.
    Kurti Z, Vegh Z, Golovics PA, Fadgyas-Freyler P, Gecse KB, Gonczi L, Gimesi-Orszagh J, Lovasz BD, Lakatos PL.
    Dig Liver Dis; 2016 Nov; 48(11):1302-1307. PubMed ID: 27481587
    [Abstract] [Full Text] [Related]

  • 39. [Treatment of chronic inflammatory bowel diseases].
    Lémann M.
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [Abstract] [Full Text] [Related]

  • 40. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
    Frøslie KF, Jahnsen J, Moum BA, Vatn MH, IBSEN Group.
    Gastroenterology; 2007 Aug; 133(2):412-22. PubMed ID: 17681162
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.